Study identifies genes associated with risk of triple-negative breast cancer
Full article:

Panel testing can identify women who are at increased risk for breast cancer.  However, those at risk for triple-negative breast cancer cannot easily be identified because other than BRCA1, genes that increase the risk for triple-negative breast cancer are unknown.  A new study uses panel testing to identify which genes increase the risk for triple-negative breast cancer. (8/23/18)

Questions To Ask Your Health Care Provider

Open Clinical Trials

The following are studies enrolling people with early-stage, TNBC.  

A number of other clinical trials for patients with early-stage TNBC can be found here.

The following clinical trials include genetic counseling and testing. 

Other genetic counseling or testing studies may be found here.



FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.